scholarly journals The impact of an encounter with a gynaecologic dermatologist on quality of life, health literacy and education satisfaction for patients with vulvar lichen sclerosus: A survey study

2021 ◽  
Author(s):  
E. M. Kolitz ◽  
J. Pineider ◽  
M. M. Mauskar ◽  
A. Rutherford
2010 ◽  
Vol 31 (4) ◽  
pp. 279-284 ◽  
Author(s):  
Hedwig P Van De Nieuwenhof ◽  
Kim A. P. Meeuwis ◽  
Theodoor E. Nieboer ◽  
Marianne C. M. Vergeer ◽  
Leon F. A. G. Massuger ◽  
...  

Doctor Ru ◽  
2021 ◽  
Vol 20 (6) ◽  
pp. 102-106
Author(s):  
N.I. Chernova ◽  
◽  
I.S. Zadorozhnaya ◽  

Study Objective: To assess the therapeutic efficiency of liposomal gelcoat with dihydroquercetin Flamena in combination therapy of vulvar lichen sclerosus (VLS). Study Design: open comparative perspective study. Materials and Methods. The study included 52 patients with VLS aged 22 to 65 years. Patients were randomised into two therapeutic groups: 27 patients in group 1 had a standard course of therapy with ultrapotent topic glucocorticosteroids (tGCS) for 3 months; 25 patients in group 2 had a standard intermittent 3-month therapy with Flamena gel for 1.5 month. Therapy efficiency was evaluated using the Dermatological Symptom Scale, visual analogue scale, and Dermatological Quality of Life Index (DQoLI). Therapeutic manipulations were assessed during 6 visits. Study Results. Flamena gel facilitated clinical remission maintenance and prolongation. Starting from visit 4, there were differences between group 1 and group 2 values. By visit 5, group 2 patients demonstrated stable regression or reduction in white spots and papules/plaques (not more than 0.8 ± 0.35 and 0.5 ± 0.26 points, respectively). At the same time, group 1 had clinical symptoms intensity rising to 1.6 ± 0.87 points (white spots) and 1.2 ± 0.9 points (papules/plaques), correlating with subjective symptoms aggravation. Effects of therapy on DQoLI were demonstrated with reduction in mean values to 4.2 ± 2.6 points (group 1) and 3.2 ± 1.4 points (group 2) by visit 2. In group 2, the values remained at 3.3 ± 0.6 points by day 60 (visit 6) of follow-up, whereas in group 1 the VLS impact over quality of life increased from mild (4.2 ± 2.6 points — visit 2) to moderate (7.1 ± 2.3 points — visit 6) in a majority of study subjects. Conclusion. A comparative study demonstrated a marked therapeutic effect and high safety profile of Flamena gel in a combination therapy of VLS patients. It improves disease prognosis due to antiinflammatory, antiseptic and regenerative action, thus allowing reducing the frequency and amount of tGCS use. Keywords: vulvar lichen sclerosus, Flamena gel, vulvar itching


2020 ◽  
Vol 14 (2) ◽  
pp. 203-210
Author(s):  
A. G. Solopova ◽  
E. E. Achkasov ◽  
A. D. Makatsariya ◽  
V. S. Moskvichyova ◽  
A. E. Ivanov

Aim: to assess the psycho-emotional profile in patients with vulvar lichen sclerosus.Materials and methods. We examined 57 patients with a diagnosis of vulvar lichen sclerosus, the average age of 35.0 ± 0.6 (from 18 to 45) years. The control group included 45 healthy women without dystrophic changes in the external genital organs, who applied for a routine examination. The following methods were used to analyze the psycho-emotional profile: WAM questionnaire (well-being, activity, mood), Hospital Anxiety and Depression Scale (HADS), the Dermatology Life Quality Index (DLQI).Results. In patients with vulvar lichen sclerosus a decrease in indicators “well-being” (24.3 ± 1.7 versus 52.4 ± 5.6 scores) and “mood” (28.7 ± 3.6 versus 58.1 ± 6.1 scores) was revealed; “activity” was changed slightly (41.2 ± 3.2 against 47.4 ± 4.9 scores). Depressive (75.4 % versus 15.6 %) and anxiety (68.4 % versus 20 %) disorders were also more common in this group. Significant deterioration in the quality of life in patients was confirmed by a DIQL (18.79 ± 4.98 scores).Conclusion. Psycho-emotional profile of patients with vulvar lichen sclerosus is characterized by a change in most of the analyzed parameters. The presence of anxiety-depressive disorders can aggravate both the general somatic state and the course of the underlying disease. So activities aimed at improving the quality of life should be included in the rehabilitation of these patients.


2021 ◽  
Vol 5 (7) ◽  
pp. 691-694
Author(s):  
Özlem HELVACİOGLU ◽  
Zeynep TOPKARCI ◽  
Çağlar HELVACIOĞLU ◽  
Ayşe KAVAK

2017 ◽  
Vol 49 (4) ◽  
pp. 573-580 ◽  
Author(s):  
Francesco Casabona ◽  
Ilaria Gambelli ◽  
Federica Casabona ◽  
Pierluigi Santi ◽  
Gregorio Santori ◽  
...  

2021 ◽  
Vol 8 (2) ◽  
pp. 32
Author(s):  
Rachel Hanford ◽  
Deborah E. Linder

Obese dogs have been shown to have a diminished quality of life; however, there is less evidence characterizing the impact of obesity on the quality of life of cats. A cross-sectional survey study was conducted among cat owners with either healthy weight cats (body condition scores of 4–5/9) or obese cats (body condition scores of 8–9/9) as determined by a veterinarian. Exclusion criteria included medical conditions (determined by physical exam and screening bloodwork). Cat owners completed surveys on quality of life and perceptions of feline obesity. Quality of life scores for obese cats had a wider range and were numerically lower compared to scores of healthy weight cats with a moderate effect size of 0.68, though this was not a statistically significant difference (71.2 ± 8.8 vs. 75.9 ± 4.1, p = 0.0881; n = 33). Owners of obese cats less frequently reported that obesity was a high risk to their cat’s health (77% [10/13]) vs. 100% [20/20]) and less frequently cited the primary caretaker as a cause of cat obesity (30% [3/10] vs. 55% [11/20]) compared to the owners of healthy weight cats. Interestingly, 97% (32/33) of all owners believed veterinarians should play a role in feline weight loss. These results suggest that some obese cats can have a potentially diminished quality of life but highlights the need for more data surrounding the impact of feline obesity and enhanced client communication strategies to best address obesity in the feline population.


Sign in / Sign up

Export Citation Format

Share Document